Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum ProMIS Neurosciences Inc PMN

ProMIS Neurosciences Inc. is a clinical-stage biotechnology company. It is focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer’s disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine applies a thermodynamic, computational... see more

NDAQ:PMN - Post Discussion

View:
Post by Speyeder999 on May 19, 2021 9:56am

Neil Warma

Warma is General Manager of A bio pharmaceutical company with a market cap of 4.2B and is coming over to Promis to pass his weekends? Don't think so...




Currently, Mr. Warma is the General Manager of I-Mab Biopharma U.S., (Nasdaq:
IMAB) a publicly traded global biopharmaceutical company committed to the discovery, development and commercialization of novel therapeutics for immuno-oncology based diseases, with offices and research labs in China (Shanghai, Beijing, Hangzhou, Hong Kong) and the U.S. (San Diego, Gaithersburg).
Comment by farmerjane on May 19, 2021 11:05am
Yes a General Manager of I-Mab, with many levels of authority above him and what ownership? I seem to recall Promis had a director for a number of years that sold a company prior for plus/minus a billion $ that resigned last fall.  Didn't help Promis get anywhere with there science!
Comment by Speyeder999 on May 19, 2021 11:42am
Him being a General manager is fine by me....it means the guy actually works for his paycheck. If Promis is actually pushing forward with clinicals trials, who'd you expect to do the legwork, Elliot? Gene? But I agree, it doesn't explain why the preceding director wasn't able to move things forward. In my opinion, i don't think the science has anything to do with it, cause in this ...more  
Comment by Mole101 on May 19, 2021 1:02pm
One person has been with PMN from the beginning, His unwillingness to part from any of his creations may have been the reason for that director resignation and moved into other ventures, after all he was brought in to achieved that .. Since last summer a new direction has taking place and maybe the new found partnerships show that willingness is beginning to show , with partnerships the ...more  
Comment by farmerjane on May 19, 2021 5:16pm
They made no mention of heading into a new direction last summer just more partnership discussions. What happend to all their products in the old direction that they produced over the years and to date that have yielded Zippo, not one being partnered or going into clinic. As far as partnerships they were with Saskatchewan Vaccine (Vido-InterVac) years ago which yielded nothing and BCNI out the ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities